Inventor · disambiguated record
Christoph Heuck
Also filed as: HEUCK CHRISTOPH
3 granted patents·14 pending applications·0 citations·filing 2014–2024
52Inventor score
Top patents by PatentIndex Score
17 records- 0179US2025084485A1Gep5 model for multiple myelomaBIOVENTURES LLC·Filed 2024·Application pending·0 cites
- 0268US2023348615A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0367US12060618B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2020·Granted Aug 13, 2024·0 cites·15 claims
- 0462US2023295333A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0562US2023250174A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0662US2023277660A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0762US2023330224A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0861US10752956B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2017·Granted Aug 25, 2020·0 cites·9 claims
- 0960US2022041745A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1059US2025109198A1Approved products for the treatment of relapsed or refractory multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1158US9822419B2GEP5 model for multiple myelomaBIOVENTURES LLC·Filed 2014·Granted Nov 21, 2017·0 cites·31 claims
- 1254US2020308297A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1352US2020316197A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1451US2024415960A1Methods for treating multiple myelomaJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1549US2020308284A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1649US2020330593A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1749US2020308296A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Heuck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →